Opinion
Video
The Importance of Serum Testosterone Levels With the Use of Androgen Receptor-Targeting Therapies
Author(s):
Panelists discuss how the STAAR study (Stein, 2018) indicates that the micronized abiraterone formulation results in lower average serum testosterone levels in 25% of patients compared to 17% with the originator formulation, potentially influencing treatment selection.
- To what extent do average serum testosterone levels guide selection between abiraterone formulations?
- STAAR study: Average serum testosterone levels≤0.1 ng/dL occurred in 25% of patients treated with micronized formulation vs 17% of patients receiving the originator formulation.
Related Videos
Related Content
